Evidence map›Paper›PMID 22641158›Full record

ArticleJournal of proteomics2012

Proteomic profiling of ATM kinase proficient and deficient cell lines upon blockage of proteasome activity.

Valeria Marzano, Simonetta Santini, Claudia Rossi, Mirco Zucchelli, Annamaria D'Alessandro, Carlo Marchetti, Michele Mingardi, Venturina Stagni, Daniela Barilà, Andrea Urbani

Open access · hybridAbstract read
In one paragraph

Article in Journal of proteomics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Valeria MarzanoProteomic and Metabonomic Laboratory, Fondazione Santa Lucia, 00143 Rome, Italy.
Simonetta Santini
Claudia Rossi
Mirco Zucchelli
Annamaria D'Alessandro
Carlo Marchetti
Michele Mingardi
Venturina Stagni
Daniela Barilà
Andrea Urbani
Fondazione Santa Lucia · ITUniversity of Rome Tor Vergata · ITUniversity of Chieti-Pescara · IT

Funding

Telethon GGP07252
6 · The paper itself

Abstract

Ataxia Telangiectasia Mutated (ATM) protein kinase is a key effector in the modulation of the functionality of some important stress responses, including DNA damage and oxidative stress response, and its deficiency is the hallmark of Ataxia Telangiectasia (A-T), a rare genetic disorder. ATM modulates the activity of hundreds of target proteins, essential for the correct balance between proliferation and cell death. The aim of this study is to evaluate the phenotypic adaptation at the protein level both in basal condition and in presence of proteasome blockage in order to identify the molecules whose level and stability are modulated through ATM expression. We pursued a comparative analysis of ATM deficient and proficient lymphoblastoid cells by label-free shotgun proteomic experiments comparing the panel of proteins differentially expressed. Through a non-supervised comparative bioinformatic analysis these data provided an insight on the functional role of ATM deficiency in cellular carbohydrate metabolism's regulation. This hypothesis has been demonstrated by targeted metabolic fingerprint analysis SRM (Selected Reaction Monitoring) on specific thermodynamic checkpoints of glycolysis. This article is part of a Special Issue entitled: Translational Proteomics.

Indexed as

Cell Cycle ProteinsDNA-Binding ProteinsGlycolysisProteasome Endopeptidase ComplexProtein Serine-Threonine KinasesTumor Suppressor ProteinsAtaxia TelangiectasiaAtaxia Telangiectasia Mutated ProteinsHeLa CellsHumansProteasome InhibitorsProtein StabilityProteomeAtaxia Telangiectasia Mutated ProteinsATM protein, humanCell Cycle ProteinsDNA-Binding ProteinsProteasome Endopeptidase ComplexProteasome InhibitorsProtein Serine-Threonine KinasesProteomeTumor Suppressor Proteins

Identifiers

PMID22641158
PMCPMC3426930
OpenAlexW2088204338

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.